Yovel I, Yaron Y, Amit A, Peyser M R, David M P, Kogosowski A, Lessing J B
In Vitro Fertilization-Embryo Transfer Unit, Serlin Maternity Hospital, Tel Aviv, Israel.
Fertil Steril. 1995 Jul;64(1):128-31.
To assess the effect of P levels on oocyte and embryo quality and pregnancy rates (PRs) in IVF and oocyte donation.
Retrospective analysis of PRs in ovum donors and their recipients with regard to P levels on day of hCG administration.
In Vitro Fertilization Units, oocyte donation programs.
In vitro fertilization patients who agreed to donate oocytes were treated by hMG alone (53 cycles) or in combination with a GnRH analog (122 cycles).
Uterine preparation in oocyte recipients consisted of 6 mg/d E2 valerate. Progesterone (100 mg/d) was added when oocytes became available. Hormonal treatment was continued until 12 weeks of gestation.
Using a series of Fisher's Exact Tests, a critical threshold for P was identified at 1.9 ng/mL (conversion factor to SI units, 3.185). With elevated P levels (> 1.9 ng/mL), lower PRs were noted for the donors (7.1% versus 17%), as well for the recipients (8.3% versus 26.7%).
Exposure to elevated P levels resulted in lower PRs for the donors and significantly lower PRs in the recipients. Because the endometria in the recipients were prepared uniformly, we conclude that this is the result of detrimental effects of P on oocyte or embryo quality.
评估磷(P)水平对体外受精(IVF)和卵母细胞捐赠中卵母细胞、胚胎质量及妊娠率(PRs)的影响。
回顾性分析卵母细胞捐赠者及其受者在注射人绒毛膜促性腺激素(hCG)当天的磷水平与妊娠率的关系。
体外受精单位,卵母细胞捐赠项目。
同意捐赠卵母细胞的体外受精患者,单独使用人绝经期促性腺激素(hMG)治疗(53个周期)或联合促性腺激素释放激素(GnRH)类似物治疗(122个周期)。
卵母细胞受者的子宫内膜准备采用戊酸雌二醇6mg/d。有可用卵母细胞时添加黄体酮(100mg/d)。激素治疗持续至妊娠12周。
通过一系列Fisher精确检验,确定磷的临界阈值为1.9ng/mL(换算为国际单位制的转换因子为3.185)。磷水平升高(>1.9ng/mL)时,捐赠者的妊娠率较低(7.1%对17%),受者的妊娠率也较低(8.3%对26.7%)。
暴露于升高的磷水平导致捐赠者妊娠率降低,受者妊娠率显著降低。由于受者的子宫内膜准备是一致的,我们得出结论,这是磷对卵母细胞或胚胎质量产生有害影响的结果。